106 related articles for article (PubMed ID: 24023342)
21. Isolation of RNA from residual BD SurePath liquid-based cytology specimens and detection of HPV E6/E7 mRNA using the PreTectt HPV-Proofer assay.
Dixon EP; King LM; Adams MD; Grønn P; Murphy PG; Brown CA; Brough GH; Skomedal H; Malinowski DP; Fischer TJ
J Virol Methods; 2008 Dec; 154(1-2):220-2. PubMed ID: 18761379
[TBL] [Abstract][Full Text] [Related]
22. Triage of women with minor cervical lesions: data suggesting a "test and treat" approach for HPV E6/E7 mRNA testing.
Sørbye SW; Fismen S; Gutteberg T; Mortensen ES
PLoS One; 2010 Sep; 5(9):e12724. PubMed ID: 20856930
[TBL] [Abstract][Full Text] [Related]
23. Prospective evaluation of E6/E7 mRNA detection by the NucliSENS Easy Q HPV assay in a stepwise protocol.
Padalko E; Van Renterghem L; Bamelis M; De Mey A; Sturtewagen Y; Vastenavond H; Weyers S; Praet M
J Med Virol; 2013 Jul; 85(7):1242-9. PubMed ID: 23918543
[TBL] [Abstract][Full Text] [Related]
24. Improved endocervical sampling and HPV viral load detection by Cervex-Brush Combi.
Depuydt CE; Benoy IH; Bailleul EJ; Vandepitte J; Vereecken AJ; Bogers JJ
Cytopathology; 2006 Dec; 17(6):374-81. PubMed ID: 17168921
[TBL] [Abstract][Full Text] [Related]
25. Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ HPV assay.
Halfon P; Benmoura D; Agostini A; Khiri H; Martineau A; Penaranda G; Blanc B
J Clin Virol; 2010 Feb; 47(2):177-81. PubMed ID: 20022804
[TBL] [Abstract][Full Text] [Related]
26. [Detection of high-risk human papillomavirus (HPV) E6 and E7 oncogene transcripts increases the specificity of the detection of a cervical intraepithelial neoplasia (CIN)].
Sotlar K; Diemer D; Stubner A; Menton S; Menton M; Dietz K; Wallwiener D; Bültmann B
Verh Dtsch Ges Pathol; 2005; 89():195-200. PubMed ID: 18035691
[TBL] [Abstract][Full Text] [Related]
27. HPV types and E6/E7 mRNA expression in cervical samples from Turkish women with abnormal cytology in Ankara, Turkey.
Tüney İ; Altay A; Ergünay K; Önder SÇ; Usubütün A; Salman MC; Bozdayi G; Karabulut E; Badur OS; Yüce K; Pinar A
Turk J Med Sci; 2017 Feb; 47(1):194-200. PubMed ID: 28263489
[TBL] [Abstract][Full Text] [Related]
28. mRNA expression in cervical specimens for determination of severe dysplasia or worse in HPV-16/18-positive squamous lesions.
Janusicova V; Mendelova A; Zubor P; Kapustova I; Svecova I; Kudela E; Burjanivova T; Lasabova Z; Danko J
J Low Genit Tract Dis; 2014 Jul; 18(3):273-80. PubMed ID: 24477172
[TBL] [Abstract][Full Text] [Related]
29. Clinical performance of human papillomavirus E6, E7 mRNA flow cytometric assay compared to human papillomavirus DNA typing.
Kottaridi C; Tsiodras S; Spathis A; Chranioti A; Pappas A; Kassanos D; Panayiotides I; Karakitsos P
Anal Quant Cytol Histol; 2011 Dec; 33(6):305-10. PubMed ID: 22590807
[TBL] [Abstract][Full Text] [Related]
30. A cohort retrospective study of high-risk HPV recurrence in Greek women after cervical lesion treatment through detection of viral E6/E7 mRNA expression.
Carcea F; Daniilidis A; Vavoulidis E; Nasioutziki M; Papanikolaou A; Dinas K
J BUON; 2020; 25(1):99-107. PubMed ID: 32277620
[TBL] [Abstract][Full Text] [Related]
31. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
32. HPV detection methods and genotyping techniques in screening for cervical cancer.
Eide ML; Debaque H
Ann Pathol; 2012 Dec; 32(6):e15-23, 401-9. PubMed ID: 23244480
[TBL] [Abstract][Full Text] [Related]
33. High-throughput cervical cancer screening using intracellular human papillomavirus E6 and E7 mRNA quantification by flow cytometry.
Narimatsu R; Patterson BK
Am J Clin Pathol; 2005 May; 123(5):716-23. PubMed ID: 15981811
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus DNA and E6/E7 mRNA testing as triage in liquid-based cytology samples from primary screening.
Andersson S; Mints M; Weiderpass E; Johansson B
Curr Pharm Des; 2013; 19(8):1508-15. PubMed ID: 23072430
[TBL] [Abstract][Full Text] [Related]
35. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma.
Lie AK; Kristensen G
Expert Rev Mol Diagn; 2008 Jul; 8(4):405-15. PubMed ID: 18598223
[TBL] [Abstract][Full Text] [Related]
37. Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion.
Cricca M; Venturoli S; Leo E; Costa S; Musiani M; Zerbini M
J Med Virol; 2009 Jul; 81(7):1276-82. PubMed ID: 19475620
[TBL] [Abstract][Full Text] [Related]
38. Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions.
Coutlée F; Trottier H; Gagnon S; Koushik A; Richardson H; Roger M; Ferenczy AS; Franco EL
J Clin Virol; 2009 Jun; 45(2):96-9. PubMed ID: 19398216
[TBL] [Abstract][Full Text] [Related]
39. E6/E7 expression of human papillomavirus types in cutaneous squamous cell dysplasia and carcinoma in immunosuppressed organ transplant recipients.
Dang C; Koehler A; Forschner T; Sehr P; Michael K; Pawlita M; Stockfleth E; Nindl I
Br J Dermatol; 2006 Jul; 155(1):129-36. PubMed ID: 16792764
[TBL] [Abstract][Full Text] [Related]
40. Intratype variations of HPV 31 and 58 in Italian women with abnormal cervical cytology.
Cento V; Rahmatalla N; Ciccozzi M; Perno CF; Ciotti M
J Med Virol; 2011 Oct; 83(10):1752-61. PubMed ID: 21837791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
